Tokyo, Aug 27, 2007 (JCN) - Toray Industries <3402> announced on August 22 that the company confirmed for the first time in the world that hepatitis C virus (HCV) particles produced using a novel HCV culture system inactivated have the potential for practical use as an HCV vaccine in experiments using mice.
The culture system was established through the company's joint research on the development of an HCV vaccine with the National Institute of Infectious Diseases (NIID) and the Tokyo Metropolitan Institute for Neuroscience (TMIN), Tokyo Metropolitan Organization for Medical Research.
Since its 2005 world-first in vitro cultivation of HCV with TMIN, Toray has been seeking the potential of HCV particlest for use as an HCV vaccine in collaboration with NIID. read more
Subscribe to:
Post Comments (Atom)
1 comment:
I was diagnosed as HEPATITIS B carrier in 2013 with fibrosis of the
liver already present. I started on antiviral medications which
reduced the viral load initially. After a couple of years the virus
became resistant. I started on HEPATITIS B Herbal treatment from
ULTIMATE LIFE CLINIC (www.ultimatelifeclinic.com) in March, 2020. Their
treatment totally reversed the virus. I did another blood test after
the 6 months long treatment and tested negative to the virus. Amazing
Post a Comment